AI-Native: The Mindset That Will Define Healthcare’s Next Decade
For about 10 years at every advertising conference, someone would declare: “This is the year of mobile.” We would all nod, chuckle, and move on. Eventually, it stopped being a…
For about 10 years at every advertising conference, someone would declare: “This is the year of mobile.” We would all nod, chuckle, and move on. Eventually, it stopped being a…
I’ve spent my career working on personalized and precision medicine and have seen outstanding advances in the field which continue to be accelerated by the use of AI. However, most…
The phrase “we are not saving lives” is a familiar refrain in advertising, a self-effacing nod to the industry’s secondary role in public life. In most contexts, it’s a healthy reminder not…
Wastewater now holds much more than just the sum of its parts: waste and water. It holds invaluable public health signals. Viral RNA shed by infected individuals can be detected…
The advertising industry is grappling with a fundamental challenge: the accelerating erosion of reliable user-level data. Third-party cookies, mobile identifiers, and even hashed email solutions are faltering in the face…
The “Dead Internet Theory” has gained quite a bit of traction since it was brought to light in 2021. According to The University of New South Wales the dead internet…
Pharmaceutical marketing has long treated healthcare providers (HCPs) and patients as separate audiences. Distinct in their needs, their influence, and their channels of communication. But as the healthcare journey grows…
As the regulatory landscape tightens around data privacy, many healthcare advertisers are forced to react, limiting functionality, scaling back targeting, or navigating consent challenges. BranchLab took a different path. From…
by Josh Walsh, Co-Founder & CEO, BranchLab A recent Harvard Law publication warns that Washington’s My Health My Data Act (WMHMD) could disrupt widely used advertising techniques. It’s right. And…
As regulations tighten, cleanroom technology offers a sustainable, compliant path forward for health advertising. The advertising technology ecosystem is at a crossroads. Eighty percent of consumers are concerned and confused…
The advertising landscape is changing, especially for healthcare and pharmaceutical companies. This January, the New York Senate approved S929 – a groundbreaking data privacy law and significant step towards greater…
Unpacking the Pivotal Harvard Law Paper. Pharmaceutical advertising is undergoing a seismic shift, and Washington State is at the epicenter. A recent paper from Harvard Law has issued a transformative…